文献速递心脑血管急症

脂蛋白脂肪酶基因罕见与常见变异与冠状动脉疾病的关联

Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease.
PubMed 文献 · JAMA · 2017-01-01
一句话结论LPL基因罕见损伤突变携带者冠心病风险增高(OR 1.84),常见变异每1-SD甘油三酯升高冠心病OR 1.51,但因果机制待研究。

该研究在2010至2015年间对心肌梗死遗传学联盟10个冠心病病例对照队列及Geisinger健康系统DiscovEHR队列进行LPL基因测序,并在全球血脂遗传学联盟(最多305 699人)和CARDIoGRAM外显子联盟(最多120 600人)中对常见变异进行基因分型。在46 891名有测序数据者中,188名(0.40%)携带LPL损伤突变,携带者甘油三酯较非携带者高19.6 mg/dL(95%CI 4.6-34.6),冠心病风险增高(OR 1.84;95%CI 1.35-2.51;P<.001)。6个常见LPL变异分析显示,甘油三酯每升高1-SD,冠心病OR为1.51(95%CI 1.39-1.64;P=1.1×10^-22)。作者结论认为LPL罕见损伤突变与更高甘油三酯水平和冠心病相关,但需进一步研究评估杂合性LPL缺陷导致冠心病的因果机制。

要点

  • 在46 891名有LPL测序数据者中,188名(0.40%;95%CI 0.35%-0.46%)携带LPL损伤突变,其中早发冠心病患者83/14 245(0.58%),对照105/32 646(0.32%)。
  • LPL损伤突变杂合携带者较非携带者血浆甘油三酯高19.6 mg/dL(95%CI 4.6-34.6),冠心病OR 1.84(95%CI 1.35-2.51;P<.001)。
  • 6个常见LPL变异分析中,甘油三酯每升高1-SD,冠心病OR 1.51(95%CI 1.39-1.64;P=1.1×10^-22)。
  • 作者结论认为LPL罕见损伤突变与更高甘油三酯水平和冠心病显著相关,但需进一步研究评估杂合性LPL缺陷导致冠心病的因果机制。

适用人群与场景

  • 来自跨国心肌梗死遗传学联盟10个冠心病病例对照队列及Geisinger健康系统DiscovEHR巢式冠心病病例对照队列、有LPL基因测序数据的46 891名个体,平均(SD)年龄50(12.6)岁,51%为女性。
  • 常见变异分析人群为全球血脂遗传学联盟最多305 699名个体和CARDIoGRAM外显子联盟最多120 600名个体。

研究设计与关键结果

  • 横断面研究:对46 891名个体行LPL基因测序,其中188名(0.40%;95%CI 0.35%-0.46%)携带LPL损伤突变,包括对照组105/32 646(0.32%)和早发冠心病组83/14 245(0.58%)。
  • 与非携带者(46 703名)相比,188名LPL损伤突变杂合携带者血浆甘油三酯更高,差值为19.6 mg/dL(95%CI 4.6-34.6),冠心病比值比OR 1.84(95%CI 1.35-2.51;P<.001)。
  • 6个常见LPL变异分析显示,甘油三酯每升高1-SD,冠心病OR为1.51(95%CI 1.39-1.64;P=1.1×10^-22)。

证据类型、等级与局限

  • 证据类型:横断面研究(病例对照队列及联盟基因分型数据),研究特异性估计值通过荟萃分析合并。
  • 局限:作者指出需进一步研究评估杂合性LPL缺陷导致冠心病的因果机制。

对床旁实践的改变

  • 作者结论认为LPL罕见损伤突变与更高甘油三酯水平和冠心病存在显著关联,但因果机制尚需进一步研究评估。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The activity of lipoprotein lipase (LPL) is the rate-determining step in clearing triglyceride-rich lipoproteins from the circulation. Mutations that damage the LPL gene (LPL) lead to lifelong deficiency in enzymatic activity and can provide insight into the relationship of LPL to human disease.

OBJECTIVE: To determine whether rare and/or common variants in LPL are associated with early-onset coronary artery disease (CAD).

DESIGN, SETTING, AND PARTICIPANTS: In a cross-sectional study, LPL was sequenced in 10 CAD case-control cohorts of the multinational Myocardial Infarction Genetics Consortium and a nested CAD case-control cohort of the Geisinger Health System DiscovEHR cohort between 2010 and 2015. Common variants were genotyped in up to 305 699 individuals of the Global Lipids Genetics Consortium and up to 120 600 individuals of the CARDIoGRAM Exome Consortium between 2012 and 2014. Study-specific estimates were pooled via meta-analysis.

EXPOSURES: Rare damaging mutations in LPL included loss-of-function variants and missense variants annotated as pathogenic in a human genetics database or predicted to be damaging by computer prediction algorithms trained to identify mutations that impair protein function. Common variants in the LPL gene region included those independently associated with circulating triglyceride levels.

MAIN OUTCOMES AND MEASURES: Circulating lipid levels and CAD.

RESULTS: Among 46 891 individuals with LPL gene sequencing data available, the mean (SD) age was 50 (12.6) years and 51% were female. A total of 188 participants (0.40%; 95% CI, 0.35%-0.46%) carried a damaging mutation in LPL, including 105 of 32 646 control participants (0.32%) and 83 of 14 245 participants with early-onset CAD (0.58%). Compared with 46 703 noncarriers, the 188 heterozygous carriers of an LPL damaging mutation displayed higher plasma triglyceride levels (19.6 mg/dL; 95% CI, 4.6-34.6 mg/dL) and higher odds of CAD (odds ratio = 1.84; 95% CI, 1.35-2.51; P < .001). An analysis of 6 common LPL variants resulted in an odds ratio for CAD of 1.51 (95% CI, 1.39-1.64; P = 1.1 × 10-22) per 1-SD increase in triglycerides.

CONCLUSIONS AND RELEVANCE: The presence of rare damaging mutations in LPL was significantly associated with higher triglyceride levels and presence of coronary artery disease. However, further research is needed to assess whether there are causal mechanisms by which heterozygous lipoprotein lipase deficiency could lead to coronary artery disease.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Khera AV, Won HH, Peloso GM, et al. Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease. JAMA. 2017. PMID: 28267856. doi:10.1001/jama.2017.0972

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。